Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abdi Ibrahim Ilac Sanayi ve Tic AS

www.abdiibrahim.com.tr

Latest From Abdi Ibrahim Ilac Sanayi ve Tic AS

Alvotech Reels In Abdi Ibrahim For Access To Turkey

In a move to take its pipeline of biosimilar monoclonal antibodies global, Alvotech has struck a deal with Abdi Ibrahim that will give it localization advantages in Turkey.

Deals Strategy

Turkish Health VC Fund Will Invest In US

Turkey will found a venture capital fund to acquire promising pharmaceutical start-ups and to support Turkish researchers in the US. The initiative comes from the industry, with support from the Turkish government. It is expected to gather pace after the elections on June 24.

Turkey United States

Turkey's Abdi Ibrahim Beats Multinationals On Domestic Pharma Market

The Turkish pharmaceutical market reached $5.6bn in 2017. Despite strong competition from multinationals, Abdi Ibrahim, a local company, was market leader last year with a turnover of $380m. It was followed by Novartis and Pfizer.

Turkey Market Intelligence

Turkish Industry Group Builds New Platform To Support Biotech

A major local pharmaceutical industry group in Turkey is leading the formation of a new biotechnology platform that will focus on lobbying the government to create a more friendly investment environment, and promote joint projects and training. Given ongoing official moves to attract investments in the pharma and biotech field, the initiative appears to align well with broader existing policies.

Turkey Biologics
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Turkey
  • Parent & Subsidiaries
  • Abdi Ibrahim Ilac Sanayi ve Tic AS
  • Senior Management
  • Candan Karabagli, CEO
    Nezih Barut, Chmn.
    Ocan Oncel, Gen. Mgr., Mktg. & Sales
    Ferhat Farsi, Dir., R&D
    Mustafa Darman, Dir., Fin.
    Matthias Heidt, Dir., Bus. Dev. Special Projects
  • Contact Info
  • Abdi Ibrahim Ilac Sanayi ve Tic AS
    Phone: (212) 366 84 00
    Resitpasa Mahallesi, Eski Büyükdere
    Caddesi
    Istanbul, 34467
    Turkey
Advertisement
Advertisement
UsernamePublicRestriction

Register